Dr Melissa Barrow
Research Fellow
Department of Microbiology and Immunology
36 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
DOI: 10.1038/s41541-025-01355-y2026
Journal article
The NKp44-1 Isoform Is an Activating Receptor for PDGF-DD Expressed on Natural Killer Cells.
DOI: 10.3390/cancers180710992025
Journal article
Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles
DOI: 10.1021/acs.analchem.5c018592025
Journal article
Adenovirus vectors can infect mouse megakaryocytes – implications for vaccine-induced thrombosis/thrombocytopenia
DOI: 10.1016/j.rpth.2025.1029092025
Journal article
Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale
DOI: 10.1002/bit.289372024
Research contracts (non-grants)
RNA Powered Antiviral Antibodies
2024
Research contracts (non-grants)
RNA Powered Antiviral Antibodies
RECENT SCHOLARLY WORKS
2024
Journal article
Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
DOI: 10.1128/msphere.00758-232024
Journal article
Epitope Mapping of Japanese Encephalitis Virus Neutralizing Antibodies by Native Mass Spectrometry and Hydrogen/Deuterium Exchange
DOI: 10.3390/biom140303742024
Journal article
Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
DOI: 10.3390/organoids30100022024
Journal article
Cutting Edge: PDGF-DD Binding to NKp44 Costimulates TLR9 Signaling and Proinflammatory Cytokine Secretion in Human Plasmacytoid Dendritic Cells
DOI: 10.4049/jimmunol.22004962023
Journal article
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
DOI: 10.3389/fmicb.2023.1065609